Abstract:1 The proposal that a,fi-methylene adenosine 5'-triphosphate (mATP) inhibits pressor responses in the pithed rat by selective desensitization of P2.-purinoceptors was examined by comparing the selectivity of its inhibitory effect on vascular responses in vitro and in vivo.2 In isolated ring preparations of rat femoral and tail artery, which had been denuded of endothelium, mATP markedly reduced the contractile response to exogenous ATP but had no effect on the response of the arteries to exogenous noradrenalin… Show more
“…29,44 Moreover, MeATP is also known to ''desensitize'' the platelet P2X1 receptor, thereby decreasing the overall Ca 2+ influx into the platelet. 45 Fig. 4 Concentration-dependent dual nature of ATP as a platelet antagonist and agonist.…”
Patient groups subject to higher occurrence of stroke (e.g., people with diabetes, cystic fibrosis, pulmonary hypertension) have reduced release of ATP from their erythrocytes (ERYs) when subjected to flow-induced deformation or pharmacological stimuli. These same groups also have platelets that are more adhesive in comparison to controls. Here we show platelet aggregation, and inhibition of that aggregation, is affected by free Ca(2+) entering the platelet through the ATP-gated P2X1 receptor. The addition of ATP (10 microM) increased the platelet NO by 26.7 +/- 7.7%. This value was decreased significantly to below basal levels in the presence of NF 449 (p < 0.001), an inhibitor of the P2X1 receptor on the platelet. Aggregation profiles measured in the presence of ATP revealed that when the P2X1 receptor was blocked, or when the measurements were performed in Ca(2+) free buffer, platelet aggregation was nearly eliminated. Our findings employing standard aggregation measurements suggest that ATP behaves as a platelet inhibitor below 1.6 x 10(-19) moles ATP per platelet; however, above this value, ATP behaves as a platelet activator. These findings suggesting a dual nature of ATP with regard to platelet behavior were confirmed by passing platelets over endothelial cells that were coated in the channels of a microfluidic device. Importantly, it was determined that ERY-derived ATP release was a major determinant of platelet adhesion to the endothelium. These findings may have implications in anti-platelet drug design as most current therapies focus on the inhibition of P2Y-type receptors. Moreover, through the use of microfluidic technologies, we have provided in vitro evidence for a possible relationship between ERY properties and platelet behavior in vivo.
“…29,44 Moreover, MeATP is also known to ''desensitize'' the platelet P2X1 receptor, thereby decreasing the overall Ca 2+ influx into the platelet. 45 Fig. 4 Concentration-dependent dual nature of ATP as a platelet antagonist and agonist.…”
Patient groups subject to higher occurrence of stroke (e.g., people with diabetes, cystic fibrosis, pulmonary hypertension) have reduced release of ATP from their erythrocytes (ERYs) when subjected to flow-induced deformation or pharmacological stimuli. These same groups also have platelets that are more adhesive in comparison to controls. Here we show platelet aggregation, and inhibition of that aggregation, is affected by free Ca(2+) entering the platelet through the ATP-gated P2X1 receptor. The addition of ATP (10 microM) increased the platelet NO by 26.7 +/- 7.7%. This value was decreased significantly to below basal levels in the presence of NF 449 (p < 0.001), an inhibitor of the P2X1 receptor on the platelet. Aggregation profiles measured in the presence of ATP revealed that when the P2X1 receptor was blocked, or when the measurements were performed in Ca(2+) free buffer, platelet aggregation was nearly eliminated. Our findings employing standard aggregation measurements suggest that ATP behaves as a platelet inhibitor below 1.6 x 10(-19) moles ATP per platelet; however, above this value, ATP behaves as a platelet activator. These findings suggesting a dual nature of ATP with regard to platelet behavior were confirmed by passing platelets over endothelial cells that were coated in the channels of a microfluidic device. Importantly, it was determined that ERY-derived ATP release was a major determinant of platelet adhesion to the endothelium. These findings may have implications in anti-platelet drug design as most current therapies focus on the inhibition of P2Y-type receptors. Moreover, through the use of microfluidic technologies, we have provided in vitro evidence for a possible relationship between ERY properties and platelet behavior in vivo.
“…Extracellular ATP is known to have a number of biological and pharmacological effects in blood vessels by acting on specific cell‐surface P 2 purinoceptors located on vascular smooth muscles 34 . In the rat caudal artery, ATP produced a vasoconstriction by acting on P 2X purinoceptors, an action that has been observed at higher concentrations of ATP (more than 100 μmol/L) 35 –37 . Although it is not possible to calculate from the present data the exact concentration of endogenous ATP released from the caudal artery that is then available to interact with tissue‐specific purinoceptors, a reasonable approximation of the amount of ATP per tissue volume can be made and is approximately 300 nmol/L.…”
Section: Discussionmentioning
confidence: 87%
“…34 In the rat caudal artery, ATP produced a vasoconstriction by acting on P2X purinoceptors, an action that has been observed at higher concentrations of ATP (more than 100 µmol/L). [35][36][37] Although it is not possible to calculate from the present data the exact concentration of endogenous ATP released from the caudal artery that is then available to interact with tissue-specific purinoceptors, a reasonable approximation of the amount of ATP per tissue volume can be made and is approximately 300 nmol/L. This value is rather close to the concentration of ATP (500 nmol/L) that was observed to increase intracellular Ca 2ϩ levels, 33 but did not produce a direct response of the smooth muscle.…”
1. To elucidate the physiological role of nitric oxide (NO) in regulating vascular tone, the effects of NG-nitro-L-arginine methyl ester (L-NAME), an NO synthase inhibitor, on the vasoconstrictor response to noradrenaline (NA) in rat caudal artery was examined. 2. NG-Nitro-L-arginine methyl ester significantly potentiated the NA-induced increase in perfusion pressure in the perfused caudal artery, but did not affect the NA-induced contraction in caudal artery ring preparations. In addition, an increase in perfusion pressure mechanically produced by a stepwise increase in flow rate was not affected by L-NAME. 3. Noradrenaline evoked a significant increase in the release of endogenous ATP and its metabolites from the perfused artery, whereas increased perfusion pressure as a result of increased flow rate did not evoke release of endogenous ATP. 4. In the presence of exogenously applied ATP, L-NAME significantly potentiated the increase in perfusion pressure produced by increased flow rate. 5. These results indicate that perfused vascular tone is regulated by endogenous NO and suggest that extracellular ATP may participate in the synthesis and release of NO by shear stress in endothelial cells in the rat caudal artery.
“…Data from Weitzell et al [13], stimulation in rat tail arteries persisted in the presence of phentolamine but were abol ished after desensitization of purine P^x re ceptors [6] by a,p-methylene-ATP. Analo gous evidence for the mechanical response followed: a,P-methylene-ATP abolished the a-adrenoceptor-antagonist-resistant neuro genic constriction of branches of the rabbit isolated ileocolic artery [7] and also reduced sympathetic vasopressor responses in pithed rats [8], although the selectivity of the desen sitization by a,p-methylene-ATP in whole animal preparations is in doubt [9,10], We summarize here our evidence for NA-ATP cotransmission in isolated blood vessels from rabbits. Attention was also paid to pre junctional 012-autoinhibition [11,12] in co transmission systems.…”
Postganglionic sympathetic cotransmission by noradrenaline (NA) and adenosine 5’-triphosphate (ATP) was studied in isolated arteries from rabbits using as tools α-adrenoceptor antagonists and αβ-methylene-ATP which first activates and then desensitizes purine P2X receptors. In the pulmonary artery, NA was the only chemical signal responsible for neurogenic vasoconstriction. In sharp contrast, ATP was the only signal eliciting electric as well as mechanical postjunctional responses in small jejunal arteries. Mixed adrenergic and purinergic transmission was found in the largest ramus caecalis of the ileocolic artery. The purinergic component prevailed in short pulse trains and early in long trains, whereas the adrenergic component prevailed in the late phases of long (20 s) trains. Prejunctional α2-adrenergic autoinhibition markedly depressed purinergic as well as adrenergic transmission as soon as a latency of about 2 s was exceeded.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.